Literature DB >> 2705448

The time course of peritoneal transport kinetics in continuous ambulatory peritoneal dialysis patients who develop sclerosing peritonitis.

R T Krediet1, D G Struijk, E W Boeschoten, G C Koomen, J M Stouthard, F J Hoek, L Arisz.   

Abstract

The time course of measurements of peritoneal solute transport in four continuous ambulatory peritoneal dialysis (CAPD) patients who developed sclerosing peritonitis is described. Loss of fluid removal capacity was found in all of them. In three, this loss was associated with an increase in peritoneal absorption of glucose from the dialysate and an increase in the transperitoneal transport rates of low-molecular-weight solutes and proteins. In the other patient a decrease in all these parameters was found. This seems to imply that the effective peritoneal surface area was increased in three patients and decreased in one. Peritoneal permeability to macromolecules remained unchanged as judged by the ratio between the clearance of IgG and albumin. Among the possible factors that contribute to the development of sclerosing peritonitis, some are likely to lead to a larger effective peritoneal surface area, like prostacyclin and the formation of new capillaries in poorly vascularized parts of the peritoneum. Others, such as extensive formation of collagen, could lead to a smaller effective surface area. Individual differences in susceptibility to these factors may lead to an increase or decrease in peritoneal solute transport rates. Follow-up measurements of peritoneal solute kinetics are necessary to identify those patients who are at risk.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2705448     DOI: 10.1016/s0272-6386(89)80036-8

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  6 in total

1.  [Dialysis quantity and dietary protein during continuous ambulatory peritoneal dialysis].

Authors:  M Schmidli; M Jacobs; U Binswanger
Journal:  Klin Wochenschr       Date:  1990-12-30

Review 2.  Encapsulating peritoneal sclerosis: the state of affairs.

Authors:  Mario R Korte; Denise E Sampimon; Michiel G H Betjes; Raymond T Krediet
Journal:  Nat Rev Nephrol       Date:  2011-08-02       Impact factor: 28.314

Review 3.  Can Free Water Transport Be Used as a Clinical Parameter for Peritoneal Fibrosis in Long-Term PD Patients?

Authors:  Raymond T Krediet; Deirisa Lopes Barreto; Dirk G Struijk
Journal:  Perit Dial Int       Date:  2015-10-16       Impact factor: 1.756

4.  Longitudinal changes in peritoneal equilibration test with or without peritonitis in children.

Authors:  A Nishi; Y Ito; Y Amamoto; K Aida; H Kato
Journal:  Pediatr Nephrol       Date:  1995-10       Impact factor: 3.714

5.  Fibrin-Induced epithelial-to-mesenchymal transition of peritoneal mesothelial cells as a mechanism of peritoneal fibrosis: effects of pentoxifylline.

Authors:  Cheng-Chung Fang; Jenq-Wen Huang; Ren-Shi Shyu; Chung-Jen Yen; Cheng-Hsiang Shiao; Chih-Kang Chiang; Rey-Heng Hu; Tun-Jun Tsai
Journal:  PLoS One       Date:  2012-09-13       Impact factor: 3.240

6.  Renal Association Clinical Practice Guideline on peritoneal dialysis in adults and children.

Authors:  Graham Woodrow; Stanley L Fan; Christopher Reid; Jeannette Denning; Andrew Neil Pyrah
Journal:  BMC Nephrol       Date:  2017-11-16       Impact factor: 2.388

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.